Israeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine

[Hamartia Antidote]

Israeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine

Israel's largest healthcare provider on Sunday reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's vaccine in the country's biggest study to date.

www.reuters.com

JERUSALEM (Reuters) - Israel’s largest healthcare provider on Sunday reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer’s vaccine in the country’s biggest study to date.

Health maintenance organization (HMO) Clalit, which covers more than half of all Israelis, said the same group was also 92% less likely to develop severe illness from the virus.

The comparison was against a group of the same size, with matching medical histories, who had not received the vaccine.

“It shows unequivocally that Pfizer’s coronavirus vaccine is extremely effective in the real world a week after the second dose, just as it was found to be in the clinical study,” said Ran Balicer, Clalit’s chief innovation officer.

He added that the data indicates the Pfizer vaccine, which was developed in partnership with Germany’s BioNTech, is even more effective two weeks or more after the second shot.

Researchers at the Weizmann Institute of Science, who have been tabulating national data, said on Sunday that a sharp decline in hospitalisation and serious illness identified earlier among the first age group to be vaccinated - aged 60 or older - was seen for the first time in those aged 55 and older.


Hospitalisations and serious illness were still rising in younger groups who began vaccinations weeks later.

Israel has been conducting a rapid vaccine rollout and its database offers insights into vaccine effectiveness and at what point countries might attain herd immunity.

 

[masterchief_mirza]

@Musings Pfizer looking very effective.

 

[Musings]

@Musings Pfizer looking very effective.

I agree. Thankfully this is the one we have had. Our 2nd dose is due in April. I think this is the way out of this crisis. Still surprised and disappointed how some Asians are simply refusing to have it.......

 

[masterchief_mirza]

I agree. Thankfully this is the one we have had. Our 2nd dose is due in April. I think this is the way out of this crisis. Still surprised and disappointed how some Asians are simply refusing to have it.......

However, the media and indeed British public perceptions shaped by the media are false and misleading.

There is a lack of uptake among Asian and black people - not because of their ethnicity (they're as logical as the next man) - but simply because of fake news being promulgated throughout various communities. The language should shift from "lack of BAME uptake" to that of exposing fake news in circulation and its sources. Indeed, the sources of fake news should be pressured and exposed mercilessly.

If you present anyone with false information, they will respond in a certain way, regardless of skin colour.

Unfortunately, British media remains transfixed by pretty colourised pigeon hole categories for all of us...because that's the sort of nonsense people click on.

 

[Beny Karachun]

I agree. Thankfully this is the one we have had. Our 2nd dose is due in April. I think this is the way out of this crisis. Still surprised and disappointed how some Asians are simply refusing to have it.......

2nd dose is kinda tough, prepare for a fever, headaches and extreme muscle soreness, you'll wanna use ibuprofen

 

[Hamartia Antidote]

 

[CAPRICORN-88]

Study just shows that it works well for Isreali genes, that all.
Will it altered our otherwise healthy DNA?
Will all these recipients all developed cancer cells later in their life?